Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 579 Records) |
| Query Trace: Colorectal Neoplasms and Egfr[original query] |
|---|
| Epithelial TGF? engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features. Nature communications 2022 12 13 (1): 7551. Flanagan Dustin J, Amirkhah Raheleh, Vincent David F, Gunduz Nuray, Gentaz Pauline, Cammareri Patrizia, McCooey Aoife J, McCorry Amy M B, Fisher Natalie C, Davis Hayley L, Ridgway Rachel A, Lohuis Jeroen, Leach Joshua D G, Jackstadt Rene, Gilroy Kathryn, Mariella Elisa, Nixon Colin, Clark William, Hedley Ann, Markert Elke K, Strathdee Douglas, Bartholin Laurent, Redmond Keara L, Kerr Emma M, Longley Daniel B, Ginty Fiona, Cho Sanghee, Coleman Helen G, Loughrey Maurice B, Bardelli Alberto, Maughan Timothy S, Campbell Andrew D, Lawler Mark, Leedham Simon J, Barry Simon T, Inman Gareth J, van Rheenen Jacco, Dunne Philip D, Sansom Owen |
| Long-term Survival Update and Extended RAS Mutational Analysis of the CAIRO2 Trial: Addition of Cetuximab to CAPOX/Bevacizumab in Metastatic Colorectal Cancer. Clinical colorectal cancer 2022 12 . Ten Hoorn Sanne, Mol Linda, Sommeijer Dirkje W, Nijman Lisanne, van den Bosch Tom, de Back Tim R, Ylstra Bauke, van Dijk Erik, van Noesel Carel J M, Reinten Roy J, Nagtegaal Iris D, Koopman Miriam, Punt Cornelis J A, Vermeulen Lou |
| Clinical and molecular characteristics of kinase domain duplications across diverse cancer types in the Chinese population. Cancer medicine 2022 11 . Lai Xiaojing, Yu Ruoying, Ou Qiuxiang, Bao Hua, Wu Xue, Shao Yang, Li Yang, Zhang Ying, Ding Qingqi |
| Molecular Typing and Clinical Characteristics of Synchronous Multiple Primary Colorectal Cancer. JAMA network open 2022 11 5 (11): e2243457. Zhao Yandong, Wu Jingjing, Pei Fengyun, Zhang Yanxiang, Bai Shaomei, Shi Lishuo, Zhang Xiang, Ma Jingjiao, Zhao Ximeng, Ma Tonghui, Wang Jianping, Huang Meijin, Fan Xinjuan, Huang J |
| Liquid biopsy to detect resistance mutations against anti-epidermal growth factor receptor therapy in metastatic colorectal cancer. World journal of gastrointestinal oncology 2022 10 14 (9): 1654-1664. Valenzuela Guillermo, Burotto Mauricio, Marcelain Katherine, González-Montero Jai |
| Identification of immune-related mechanisms of cetuximab induced skin toxicity in colorectal cancer patients. PloS one 2022 17 (10): e0276497. Park Jin Hyun, Kim Mi Young, Choi In Sil, Kim Ji-Won, Kim Jin Won, Lee Keun-Wook, Kim Jin-S |
| [Laser microdissection for the analysis of molecular heterogeneity in colorectal cancer]. Pathologie (Heidelberg, Germany) 2022 10 43 (Suppl 1): 36-41. Maag Nathalie, Arndt Annette, Steinestel Konr |
| The Impact of Sidedness on the Efficacy of Anti-EGFR-Based First-Line Chemotherapy in Advanced Colorectal Cancer Patients in Real-Life Setting-A Nation-Wide Retrospective Analysis (RACER). Cancers 2023 9 15 (17): . Pawe? Micha? Potocki, Rafa? Wi?niowski, Dominik Haus, Zbyszko Chowaniec, Maciej Kozaczka, Magdalena Kustra, Marzenna Samborska-Plewicka, Marcin Szweda, Danuta Starzyczny-S?ota, Magdalena Michalik, Grzegorz S?omian, Aneta Lebiedzi?ska, Natalia Jonak-Olczyk, Natalia ?aszewska-Krai?ska, Krzysztof Adamowicz, Piotr Kolenda, Anna Drosik-Kwa?niewska, Marek Szwiec, Robert Dziura, Justyna Czech, Maria D?browska, Ewa Nowakowska-Zajdel, Ewa Klank-Soko?owska, Kamil Konopka, ?ukasz Kwinta, Jolanta Dobrza?ska, Piotr J Wysoc |
| Unveiling the metal mutation nexus: Exploring the genomic impacts of heavy metal exposure in lung adenocarcinoma and colorectal cancer. Journal of hazardous materials 2023 9 461 132590. Mengyuan Liu, Yuting Hong, Xiaohong Duan, Qiming Zhou, Jing Chen, Siyao Liu, Junyan Su, Li Han, Jiali Zhang, Beifang N |
| KRAS/NRAS Mutations Associated with Distant Metastasis and BRAF/PIK3CA Mutations Associated with Poor Tumor Differentiation in Colorectal Cancer. International journal of general medicine 2023 9 16 4109-4120. Juanzi Zeng, Wenwei Fan, Jiaquan Li, Guowu Wu, Heming |
| KRAS Mutation Status in Bulgarian Patients with Advanced and Metastatic Colorectal Cancer. International journal of molecular sciences 2023 8 24 (16): . Maria Radanova, Galya Mihaylova, George St Stoyanov, Vyara Draganova, Aleksandar Zlatarov, Nikola Kolev, Eleonora Dimitrova, Nikolay Conev, Diana Ivano |
| Negative hyper-selection of patients with HER2-positive and RAS wild-type metastatic colorectal cancer receiving dual HER2 blockade: the PRESSING-HER2 study. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 8 . Giovanni Randon, Yoshiaki Nakamura, Rona Yaeger, Sara Lonardi, Chiara Cremolini, Elena Élez, Federico Nichetti, Filippo Ghelardi, Vincenzo Nasca, Francesca Bergamo, Veronica Conca, Javier Ros, Hideaki Bando, Giulia Maddalena, Simone Oldani, Michele Prisciandaro, Alessandra Raimondi, Alexa B Schrock, Luca Agnelli, Henry Walch, Takayuki Yoshino, Filippo Pietranton |
| Effects and risk factors of TAS-102 in real-world patients with metastatic colorectal cancer, EROTAS-R study. International journal of clinical oncology 2023 8 . Naohisa Yoshida, Yoshiaki Kuriu, Jun Ikeda, Michihiro Kudou, Toshihiko Kirishima, Tetsuya Okayama, Koji Miyagawa, Tsuyoshi Takagi, Masayoshi Nakanishi, Toshifumi Doi, Takeshi Ishikawa, Yoshito Itoh, Eigo Otsu |
| The BEETS (JACCRO CC-18) trial: an observational and translational study of BRAF-mutated metastatic colorectal cancer. Future oncology (London, England) 2023 7 19 (17): 1165-1174. Chiaki Inagaki, Ryo Matoba, Satoshi Yuki, Manabu Shiozawa, Akihito Tsuji, Eisuke Inoue, Kei Muro, Wataru Ichikawa, Masashi Fujii, Yu Sunaka |
| Correlation between KRAS and NRAS mutational status and clinicopathological features in 414 cases of metastatic colorectal cancer in Morocco: the largest North African case series. BMC gastroenterology 2023 6 23 (1): 193. Youssef Mahdi, Mouna Khmou, Amine Souadka, Hajar El Agouri, Soumaya Ech-Charif, Chaimaa Mounjid, Basma El Khannous |
| A multi-institutional observational study evaluating the incidence and the clinicopathological characteristics of NeoRAS wild-type metastatic colorectal cancer. Translational oncology 2023 6 35 101718. Hiroki Osumi, Atsuo Takashima, Akira Ooki, Yuri Yoshinari, Takeru Wakatsuki, Hidekazu Hirano, Izuma Nakayama, Natsuko Okita, Ryoichi Sawada, Kota Ouchi, Koshiro Fukuda, Shota Fukuoka, Mariko Ogura, Daisuke Takahari, Keisho Chin, Hirokazu Shoji, Ken Kato, Naoki Ishizuka, Narikazu Boku, Kensei Yamaguchi, Eiji Shinoza |
| Clinical Validation of Plasma-Based Genotyping for RAS and BRAF V600E Mutation in Metastatic Colorectal Cancer: SCRUM-Japan GOZILA Substudy. JCO precision oncology 2023 6 7 e2200688. Yu Aoki, Yoshiaki Nakamura, Tadamichi Denda, Takashi Ohta, Taito Esaki, Manabu Shiozawa, Kensei Yamaguchi, Kentaro Yamazaki, Yu Sunakawa, Takeshi Kato, Naohiro Okano, Hiroya Taniguchi, Taro Sato, Eiji Oki, Tomohiro Nishina, Yoshito Komatsu, Nobuhisa Matsuhashi, Masahiro Goto, Hisateru Yasui, Koushiro Ohtsubo, Toshikazu Moriwaki, Naoki Takahashi, Yosuke Horita, Shogen Boku, Masashi Wakabayashi, Takashi Ikeno, Ryuta Mitani, Mihoko Yuasa, Takayuki Yoshi |
| Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 6 41 (18): 3278-3286. Rafael G Amado, Michael Wolf, Marc Peeters, Eric Van Cutsem, Salvatore Siena, Daniel J Freeman, Todd Juan, Robert Sikorski, Sid Suggs, Robert Radinsky, Scott D Patterson, David D Cha |
| RETRO-TAS, a Retrospective Observational Study of Trifluridine/Tipiracil in Chemorefractory Metastatic Colorectal Cancer. Biomedicines 2023 5 11 (5): . Anna Koumarianou, Anastasios Ntavatzikos, David Symeonidis, Christos Vallilas, Maria Giannakakou, Georgios Papaxoinis, Spyridon Xynogalos, Ioannis Boukovinas, Stamatina Demiri, Katerina Kampoli, Georgios Oikonomopoulos, Epaminontas Samantas, Eleni Res, Nikolaos Androulakis, Georgia Vourli, Ioannis Souglakos, Michalis Karamouz |
| Identification of KRAS mutation and HER2 expression in Indonesian colorectal cancer population: a cross-sectional study. Annals of medicine and surgery (2012) 2023 5 85 (5): 1761-1768. Reno Rudiman, Alma Wijaya, Yunia Sribudiani, Hardi Siswo Soedjana, Hesti Lina Wiraswati, Etis Pramaswati, Prapanca Nugraha, Kiki Lukm |
| A single-center retrospective analysis of the efficacy and safety of a modified regimen of irinotecan plus S-1 (IRIS) with molecular targeting agents as second-line chemotherapy in Japanese patients with recurrent or nonresectable colorectal cancer. Journal of gastrointestinal oncology 2023 5 14 (2): 663-675. Shigeo Higami, Masaya Mukai, Daiki Yokoyama, Syuji Uda, Rin Abe, Nana Mamuro, Kyoko Kishima, Sayuri Hasegawa, Takayuki Tajima, Eiji Nomura, Hiroyasu Makuuc |
| Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial. JAMA oncology 2023 5 . Stefania Napolitano, Vincenzo De Falco, Giulia Martini, Davide Ciardiello, Erika Martinelli, Carminia Maria Della Corte, Lucia Esposito, Vincenzo Famiglietti, Alessandra Di Liello, Antonio Avallone, Claudia Cardone, Alfonso De Stefano, Vincenzo Montesarchio, Maria Giulia Zampino, Roberto Bordonaro, Mario Scartozzi, Daniele Santini, Massimo Di Maio, Ferdinando De Vita, Lucia Altucci, Francesca Marrone, Fortunato Ciardiello, Teresa Troia |
| Genomic profiles of Indonesian colorectal cancer patients. F1000Research 2023 5 11 443. Murdani Abdullah, Sofy Meilany, Hidayat Trimarsanto, Safarina G Malik, Ninik Sukartini, Firhat Idrus, Saskia A Nursyirwan, Virly N Muzellina, Rabbinu R Pribadi, Amanda P Utari, Hasan Maulahela, Ari F Sy |
| Genomic landscape and survival analysis of ctDNA "neo-RAS wild-type" patients with originally RAS mutant metastatic colorectal cancer. Frontiers in oncology 2023 4 13 1160673. Nicolazzo Chiara, Magri Valentina, Marino Luca, Belardinilli Francesca, Di Nicolantonio Federica, De Renzi Gianluigi, Caponnetto Salvatore, De Meo Michela, Giannini Giuseppe, Santini Daniele, Cortesi Enrico, Gazzaniga Pao |
| Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer. Frontiers in oncology 2023 4 13 1147497. Mauri Gianluca, Patelli Giorgio, Gori Viviana, Lauricella Calogero, Mussolin Benedetta, Amatu Alessio, Bencardino Katia, Tosi Federica, Bonazzina Erica, Bonoldi Emanuela, Bardelli Alberto, Siena Salvatore, Sartore-Bianchi Andr |
| Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials. Cancers 2023 4 15 (7): . Ciardiello Davide, Napolitano Stefania, Famiglietti Vincenzo, Esposito Lucia, De Falco Vincenzo, Di Liello Alessandra, Avallone Antonio, Maiello Evaristo, Pietrantonio Filippo, Cremolini Chiara, Zampino Maria Giulia, Fazio Nicola, Troiani Teresa, Martinelli Erika, Ciardiello Fortunato, Martini Giul |
| Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments. Annals of oncology : official journal of the European Society for Medical Oncology 2023 3 . Ros J, Matito J, Villacampa G, Comas R, Garcia A, Martini G, Baraibar I, Saoudi N, Salvà F, Martin Á, Antista M, Toledo R, Martinelli E, Pietrantonio F, Boccaccino A, Cremolini C, Dientsmann R, Tabernero J, Vivancos A, Elez |
| Anti-epidermal growth factor receptor treatment for patients with NeoRAS wild-type metastatic colorectal cancer: a case report of two cases. Therapeutic advances in medical oncology 2023 11 15 17588359231216090. Kazuaki Harada, Satoshi Yuki, Yasuyuki Kawamoto, Takeaki Nakamura, Shiho Kaneko, Koichi Ishida, Naoya Sakamoto, Yoshito Komat |
| Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis. BMC cancer 2023 11 23 (1): 1117. Xiaona Lu, Yuyao Li, Yue Li, Xuemei Zhang, Jia Shi, Hai Feng, Zhuo Yu, Yueqiu G |
| Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C. The New England journal of medicine 2023 10 . Marwan G Fakih, Lisa Salvatore, Taito Esaki, Dominik P Modest, David P Lopez-Bravo, Julien Taieb, Michalis V Karamouzis, Erika Ruiz-Garcia, Tae-Won Kim, Yasutoshi Kuboki, Fausto Meriggi, David Cunningham, Kun-Huei Yeh, Emily Chan, Joseph Chao, Yaneth Saportas, Qui Tran, Chiara Cremolini, Filippo Pietranton |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: